Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about DNMT3A: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
| Gene Symbol | DNMT3A |
| Full Name | DNA Methyltransferase 3 Alpha |
| Aliases | DNA Methyltransferase 3A |
| Chromosome | 2p23 |
| Protein Type | Transferase |
| Function | DNMT3A encodes DNA methyltransferase 3 alpha, a de novo DNA methyltransferase that establishes new DNA methylation patterns during development and in adult tissues. |
| Primary Expression | neurons during development and in adulthood |
| Molecular Weight | 130 kDa |
| Pathways | Dna Methylation, Epigenetic |
| UniProt ID | [Q9Y6K4](https://www.uniprot.org/uniprot/Q9Y6K4) |
| Ensembl ID | ENSG00000119772 |
| OMIM | 602950 |
| GeneCards | DNMT3A |
| Human Protein Atlas | DNMT3A |
| Associated Diseases | Als, Alzheimer, Cancer, Cardiovascular, Crohn'S Disease |
| Known Drugs/Compounds | GEMCITABINE |
| Interactions | AGING, ALZHEIMER, ALZHEIMER'S DISEASE, AND, ASXL1, BACE1 |
| SciDEX Hypotheses | DNMT3A-Mediated de novo Methylation Corrects 'Epig |
| KG Connections | 288 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
DNMT3A["DNMT3A"]
DNMT3A -->|"target for"| Cancer["Cancer"]
DNMT3A -->|"target for"| Cardiovascular["Cardiovascular"]
DNMT3A -->|"activates"| Inflammation["Inflammation"]
DNMT3A -->|"target for"| Alzheimer["Alzheimer"]
DNMT3A -->|"target for"| Heart_Failure["Heart Failure"]
DNMT3A -->|"activates"| Als["Als"]
DNMT3A -->|"target for"| Leukemia["Leukemia"]
DNMT3A -->|"expressed in"| Ms["Ms"]
ASXL1["ASXL1"] -->|"activates"| DNMT3A
SF3B1["SF3B1"] -->|"activates"| DNMT3A
TET2["TET2"] -->|"activates"| DNMT3A
TP53["TP53"] -->|"activates"| DNMT3A
U2AF1["U2AF1"] -->|"activates"| DNMT3A
INFLAMMATION["INFLAMMATION"] -->|"activates"| DNMT3A
TFE3["TFE3"] -->|"regulates"| DNMT3A
DOT1L["DOT1L"] -->|"regulates"| DNMT3A
AMPK["AMPK"] -->|"regulates"| DNMT3A
TFEB["TFEB"] -->|"regulates"| DNMT3A| Target | Relation | Type | Str |
|---|---|---|---|
| Epigenetics | involved_in | process | 0.95 |
| Crohn's Disease | risk_factor_for | disease | 0.85 |
| Chronic Inflammation | regulates | process | 0.85 |
| Crohn'S Disease | associated_with | disease | 0.85 |
| Immune Responses | modifies | process | 0.80 |
| Immune Response | regulates | process | 0.80 |
| Chronic Inflammation | promotes | process | 0.80 |
| Leukemia | associated_with | disease | 0.80 |
| immune response | modulates | process | 0.80 |
| Clonal Hematopoiesis | contributes_to | biological_process | 0.80 |
| NEUROINFLAMMATION | regulates | entity | 0.75 |
| BRAF | interacts_with | gene | 0.75 |
| FOXO3 | regulates | gene | 0.70 |
| BACE1 | inhibits | gene | 0.70 |
| DNA_methylation | catalyzes | pathway | 0.70 |
| epigenetic regulation | participates_in | pathway | 0.70 |
| Heart Failure | therapeutic_target | disease | 0.65 |
| Inflammation | expressed_in | disease | 0.65 |
| Neuroinflammation | expressed_in | disease | 0.65 |
| Autism | expressed_in | disease | 0.65 |
| Carcinoma | expressed_in | disease | 0.65 |
| Cancer | therapeutic_target | disease | 0.65 |
| Cardiovascular | therapeutic_target | disease | 0.65 |
| Inflammation | activates | disease | 0.65 |
| Alzheimer | therapeutic_target | disease | 0.65 |
| Aging | activates | disease | 0.65 |
| neurons | expressed_in | cell_type | 0.65 |
| Senescence | activates | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| Neurodegeneration | activates | disease | 0.65 |
| Cardiovascular | associated_with | disease | 0.65 |
| Osteoporosis | associated_with | disease | 0.65 |
| Heart Failure | associated_with | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Alzheimer | associated_with | disease | 0.65 |
| GEMCITABINE | activates | drug | 0.65 |
| ALS | associated_with | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Ms | associated_with | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Leukemia | therapeutic_target | disease | 0.65 |
| Als | causes | disease | 0.65 |
| Inflammation | causes | disease | 0.65 |
| Cancer | causes | disease | 0.65 |
| Cardiovascular | causes | disease | 0.65 |
| Heart Failure | activates | disease | 0.65 |
| Ms | expressed_in | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Alzheimer | activates | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| h-e5f1182b | targets_gene | hypothesis | 0.90 |
| WNT SIGNALING | regulates | pathway | 0.70 |
| CREB | protects_against | gene | 0.70 |
| DNMT1 | stabilizes | gene | 0.70 |
| DNMT1 | regulates | gene | 0.65 |
| DNMT1 | associated_with | gene | 0.65 |
| FOXO3 | targets | gene | 0.60 |
| TET2 | activates | gene | 0.60 |
| TP53 | activates | gene | 0.60 |
| U2AF1 | activates | gene | 0.60 |
| TET2 | regulates | gene | 0.60 |
| TFAM | regulates | gene | 0.60 |
| RBPJ | regulates | gene | 0.60 |
| CGAS | therapeutic_target | gene | 0.60 |
| HDAC10 | activates | gene | 0.60 |
| HDAC1 | activates | gene | 0.60 |
| ASXL1 | interacts_with | gene | 0.60 |
| ASXL1 | regulates | gene | 0.60 |
| MITOCHONDRIAL DYSFUNCTION | activates | gene | 0.60 |
| OXIDATIVE STRESS | activates | gene | 0.60 |
| RNA | expressed_in | gene | 0.60 |
| CREB | targets | gene | 0.60 |
| SF3B1 | activates | gene | 0.60 |
| ASXL1 | activates | gene | 0.60 |
| TP53 | associated_with | gene | 0.60 |
| TET2 | associated_with | gene | 0.60 |
| OCT4 | activates | gene | 0.60 |
| MYC | activates | gene | 0.60 |
| SOX2 | activates | gene | 0.60 |
| KLF4 | activates | gene | 0.60 |
| BACH2 | implicated_in | gene | 0.60 |
| DENND1B | implicated_in | gene | 0.60 |
| ASXL1 | biomarker_for | gene | 0.60 |
| MITOCHONDRIAL DNA | regulates | gene | 0.60 |
| FBXW7 | therapeutic_target | gene | 0.60 |
| AND | regulates | gene | 0.60 |
| MITOCHONDRIA | regulates | gene | 0.60 |
| ALZHEIMER | therapeutic_target | gene | 0.60 |
| CANCER | therapeutic_target | gene | 0.60 |
| ALZHEIMER'S DISEASE | therapeutic_target | gene | 0.60 |
| PPM1D | activates | gene | 0.60 |
| NEURODEGENERATION | activates | gene | 0.60 |
| C-MYC | activates | gene | 0.60 |
| NPM1 | associated_with | gene | 0.60 |
| AND | activates | gene | 0.60 |
| MMP9 | regulates | gene | 0.60 |
| IL10 | regulates | gene | 0.60 |
| MMP2 | regulates | gene | 0.60 |
| PENK | expressed_in | gene | 0.60 |
| NCAM1 | expressed_in | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| DNMT3A-Mediated de novo Methylation Corrects 'Epigenetic Sca | 0.460 | neurodegeneration | Investigate mechanisms of epigenetic rep |
Scientific analyses that reference this entity
spatial memory | 2026-04-08 | 0 hypotheses
neurodegeneration | 2026-04-04 | 14 hypotheses Top: 0.651
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.86 · 2026-04-12
closed · Rounds: 5 · Score: 0.95 · 2026-04-12
closed · Rounds: 4 · Score: 0.95 · 2026-04-09